首页 > 最新文献

Research in Pharmaceutical Sciences最新文献

英文 中文
A bioinformatics approach of specificity protein transcription factors in head and neck squamous cell carcinoma. 头颈部鳞状细胞癌特异性蛋白转录因子的生物信息学方法。
IF 2.1 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-07-01 eCollection Date: 2024-06-01 DOI: 10.4103/RPS.RPS_171_23
Adel Rezvani Sichani, Ziba Rezvani Sichani, Behnaz Yazdani, Mehdi Azizmohammad Looha, Hajar Sirous

Background and purpose: The seventh most common type of cancer with increasing diagnosis rates around the world is head and neck squamous cell carcinoma (HNSCC). Specificity proteins (SPs) have been known for their role in the regulation of cellular division, growth, and apoptotic pathways in various cancers. In this work, we analyzed the expression levels of SPs in HNSCC to assess their diagnostic and prognostic biomarker potential.

Experimental approach: Differential gene expression and correlation analysis methods were used to determine the top dysregulated genes in HNSCC. Functional enrichment and protein-protein interaction analyses were done with the DAVID database and Cytoscape software to understand their function and biological processes. Receiver operating test, logistic regression, and Cox regression analyses were performed to check SP genes' diagnostic and prognostic potential.

Findings/results: SP1 (LogFC = -0.27, P = 0.0013) and SP2 (LogFC = -0.20, P = 0.0019) genes were upregulated in HNSCC samples, while SP8 (LogFC = 2.57, P < 0.001) and SP9 (LogFC = 2.57, P < 0.001) genes were downregulated in cancer samples. A moderate positive correlation was observed among the expression levels of SP1, SP2, and SP3 genes. The SP8 and SP9 genes with AUC values of 0.79 and 0.75 demonstrated diagnostic potential which increased to 0.84 when both genes were assessed by logistic regression test. Also, the SP1 gene held a marginally significant prognostic potential.

Conclusion and implications: Our findings clarify the potential of SP transcription factors as candidate diagnostic and prognostic biomarkers for early screening and treatment of HNSCC.

背景和目的:头颈部鳞状细胞癌(HNSCC)是全球第七大常见癌症类型,其诊断率不断上升。特异性蛋白(SPs)因其在各种癌症的细胞分裂、生长和凋亡途径的调控中发挥作用而为人所知。在这项工作中,我们分析了 SPs 在 HNSCC 中的表达水平,以评估其诊断和预后生物标志物的潜力:实验方法:采用差异基因表达和相关性分析方法确定 HNSCC 中的顶级失调基因。利用 DAVID 数据库和 Cytoscape 软件进行功能富集和蛋白质相互作用分析,以了解其功能和生物学过程。通过接收者操作检验、逻辑回归和 Cox 回归分析来检验 SP 基因的诊断和预后潜力:SP1(LogFC = -0.27,P = 0.0013)和SP2(LogFC = -0.20,P = 0.0019)基因在HNSCC样本中上调,而SP8(LogFC = 2.57,P < 0.001)和SP9(LogFC = 2.57,P < 0.001)基因在癌症样本中下调。SP1、SP2和SP3基因的表达水平呈中度正相关。SP8和SP9基因的AUC值分别为0.79和0.75,具有诊断潜力。此外,SP1 基因在预后方面的潜力也略有显著性:我们的研究结果阐明了 SP 转录因子作为 HNSCC 早期筛查和治疗的候选诊断和预后生物标志物的潜力。
{"title":"A bioinformatics approach of specificity protein transcription factors in head and neck squamous cell carcinoma.","authors":"Adel Rezvani Sichani, Ziba Rezvani Sichani, Behnaz Yazdani, Mehdi Azizmohammad Looha, Hajar Sirous","doi":"10.4103/RPS.RPS_171_23","DOIUrl":"10.4103/RPS.RPS_171_23","url":null,"abstract":"<p><strong>Background and purpose: </strong>The seventh most common type of cancer with increasing diagnosis rates around the world is head and neck squamous cell carcinoma (HNSCC). Specificity proteins (SPs) have been known for their role in the regulation of cellular division, growth, and apoptotic pathways in various cancers. In this work, we analyzed the expression levels of SPs in HNSCC to assess their diagnostic and prognostic biomarker potential.</p><p><strong>Experimental approach: </strong>Differential gene expression and correlation analysis methods were used to determine the top dysregulated genes in HNSCC. Functional enrichment and protein-protein interaction analyses were done with the DAVID database and Cytoscape software to understand their function and biological processes. Receiver operating test, logistic regression, and Cox regression analyses were performed to check SP genes' diagnostic and prognostic potential.</p><p><strong>Findings/results: </strong>SP1 (LogFC = -0.27, <i>P</i> = 0.0013) and SP2 (LogFC = -0.20, <i>P</i> = 0.0019) genes were upregulated in HNSCC samples, while SP8 (LogFC = 2.57, <i>P</i> < 0.001) and SP9 (LogFC = 2.57, <i>P</i> < 0.001) genes were downregulated in cancer samples. A moderate positive correlation was observed among the expression levels of SP1, SP2, and SP3 genes. The SP8 and SP9 genes with AUC values of 0.79 and 0.75 demonstrated diagnostic potential which increased to 0.84 when both genes were assessed by logistic regression test. Also, the SP1 gene held a marginally significant prognostic potential.</p><p><strong>Conclusion and implications: </strong>Our findings clarify the potential of SP transcription factors as candidate diagnostic and prognostic biomarkers for early screening and treatment of HNSCC.</p>","PeriodicalId":21075,"journal":{"name":"Research in Pharmaceutical Sciences","volume":"19 3","pages":"287-302"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11257197/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isolation of a novel quercetin derivative from Terminalia chebula and RT-PCR-assisted probing to investigate its DNA repair in hepatoma cells. 从Terminalia chebula中分离出一种新型槲皮素衍生物,并通过RT-PCR辅助探针研究其在肝癌细胞中的DNA修复作用。
IF 2.1 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-07-01 eCollection Date: 2024-06-01 DOI: 10.4103/RPS.RPS_56_23
Kallyadan Soumya, Karickal Raman Haridas, Jesna James, Sudhakaran Sudheesh

Background and purpose: DNA damage can lead to carcinogenesis if replication proceeds without proper repair. This study focused on the purification of a novel quercetin derivative present in Terminalia chebula fruit and studied its protective role in hepatoma cells due to H2O2-DNA damage.

Experimental approach: The pure compound obtained from the silica gel column was subjected to structural characterization using spectroscopic techniques. MTT assay was employed to select a non-toxic concentration of the isolated compounds on HepG2 and Chang liver cells. The antigenotoxic property of the compound on HepG2 and Chang liver cells was carried out by alkaline comet assay. Analyses of expression levels of mRNA for two DNA repair enzymes, OGG1 and NEIL1, in HepG2 and Chang liver cells, were carried out using the RT-PCR method.

Findings/results: The pure compound obtained from the fraction-5 of diethyl ether extract was identified as a novel quercetin derivative and named 7-(but-2-en-1-yloxy)-2-(4(but-2-en-1-yloxy)-3-hydroxyphenyl)-3- (hexa-2,4-dien-1-yloxy)-6-hydroxy-4H-chromen-4-one. This compound recorded modest toxicity at the highest concentration tested (percentage cell viability at 100 μg/mL was 64.71 ± 0.38 for HepG2 and 45.32 ± 0.07 for Chang liver cells). The compound has demonstrated noteworthy protection against H2O2-induced DNA damage in both cell lines. Analyses of mRNA expression levels for enzymes OGGI and NEIL1 enzymes in HepG2 and Chang liver cells asserted the protective role of the isolated compound against H2O2-induced DNA damage.

Conclusion and implication: The protective effect of a novel quercetin derivative isolated from T. chebula in the hepatoma cells is reported here for the first time.

背景和目的:如果复制过程中没有进行适当的修复,DNA损伤会导致癌变。本研究的重点是纯化诃子果实中的一种新型槲皮素衍生物,并研究其在肝癌细胞因 H2O2-DNA 损伤中的保护作用:实验方法:利用光谱技术对从硅胶柱中获得的纯化合物进行结构鉴定。实验方法:利用光谱技术对从硅胶柱中获得的纯化合物进行结构表征,并采用 MTT 法选择分离出的化合物对 HepG2 和 Chang 肝细胞的无毒浓度。通过碱性彗星试验检测了化合物对 HepG2 和 Chang 肝细胞的抗原毒性。采用 RT-PCR 方法分析了两种 DNA 修复酶(OGG1 和 NEIL1)mRNA 在 HepG2 和 Chang 肝细胞中的表达水平:从二乙醚提取物馏分-5中获得的纯化合物被鉴定为一种新型槲皮素衍生物,并命名为7-(丁-2-烯-1-氧基)-2-(4(丁-2-烯-1-氧基)-3-羟基苯基)-3-(己-2,4-二烯-1-氧基)-6-羟基-4H-色烯-4-酮。在测试的最高浓度下,该化合物具有适度毒性(在 100 μg/mL 浓度下,HepG2 细胞的存活率为 64.71 ± 0.38,Chang 肝细胞的存活率为 45.32 ± 0.07)。在这两种细胞系中,该化合物对 H2O2 诱导的 DNA 损伤都有显著的保护作用。对 HepG2 和 Chang 肝细胞中 OGGI 和 NEIL1 酶的 mRNA 表达水平的分析表明,分离出的化合物对 H2O2- 诱导的 DNA 损伤具有保护作用:本文首次报道了从星云草中分离出的一种新型槲皮素衍生物对肝癌细胞的保护作用。
{"title":"Isolation of a novel quercetin derivative from <i>Terminalia chebula</i> and RT-PCR-assisted probing to investigate its DNA repair in hepatoma cells.","authors":"Kallyadan Soumya, Karickal Raman Haridas, Jesna James, Sudhakaran Sudheesh","doi":"10.4103/RPS.RPS_56_23","DOIUrl":"10.4103/RPS.RPS_56_23","url":null,"abstract":"<p><strong>Background and purpose: </strong>DNA damage can lead to carcinogenesis if replication proceeds without proper repair. This study focused on the purification of a novel quercetin derivative present in <i>Terminalia chebula</i> fruit and studied its protective role in hepatoma cells due to H<sub>2</sub>O<sub>2</sub>-DNA damage.</p><p><strong>Experimental approach: </strong>The pure compound obtained from the silica gel column was subjected to structural characterization using spectroscopic techniques. MTT assay was employed to select a non-toxic concentration of the isolated compounds on HepG2 and Chang liver cells. The antigenotoxic property of the compound on HepG2 and Chang liver cells was carried out by alkaline comet assay. Analyses of expression levels of mRNA for two DNA repair enzymes, OGG1 and NEIL1, in HepG2 and Chang liver cells, were carried out using the RT-PCR method.</p><p><strong>Findings/results: </strong>The pure compound obtained from the fraction-5 of diethyl ether extract was identified as a novel quercetin derivative and named 7-(but-2-en-1-yloxy)-2-(4(but-2-en-1-yloxy)-3-hydroxyphenyl)-3- (hexa-2,4-dien-1-yloxy)-6-hydroxy-4H-chromen-4-one. This compound recorded modest toxicity at the highest concentration tested (percentage cell viability at 100 μg/mL was 64.71 ± 0.38 for HepG2 and 45.32 ± 0.07 for Chang liver cells). The compound has demonstrated noteworthy protection against H<sub>2</sub>O<sub>2</sub>-induced DNA damage in both cell lines. Analyses of mRNA expression levels for enzymes OGGI and NEIL1 enzymes in HepG2 and Chang liver cells asserted the protective role of the isolated compound against H<sub>2</sub>O<sub>2</sub>-induced DNA damage.</p><p><strong>Conclusion and implication: </strong>The protective effect of a novel quercetin derivative isolated from <i>T. chebula</i> in the hepatoma cells is reported here for the first time.</p>","PeriodicalId":21075,"journal":{"name":"Research in Pharmaceutical Sciences","volume":"19 3","pages":"303-318"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11257194/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recombinant production of interleukin-1 receptor antagonist in fusion to albumin binding domain with potential affinity to human serum albumin. 重组生产与白蛋白结合域融合的白细胞介素-1 受体拮抗剂,与人血清白蛋白具有潜在的亲和力。
IF 2.1 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-07-01 eCollection Date: 2024-06-01 DOI: 10.4103/RPS.RPS_41_23
Fatemeh Shafiee, Ali Yazdani

Background and purpose: Anakinra must be injected daily due to its short half-life and this leads to lower patient compliance. Therefore, the aim of this study was to produce an interleukin-1 receptor antagonist (IL-1Ra) with albumin binding domain (ABD) as a novel fusion protein and evaluate its binding ability to albumin and its biological effects.

Experimental approach: The three-dimensional structure of IL-1Ra-ABD was predicted by MODELLER software and its interaction with IL-1R was evaluated by the HADDOCK server. The expression of IL-1Ra-ABD was performed in E. coli in fusion with intein 1 of pTWIN1 in soluble form and then purified. The affinity of IL-1Ra-ABD to human serum albumin (HSA) was determined on native-PAGE, and its release percent toward time was evaluated. Moreover, an MTT assay was used to determine the antagonizing properties of recombinant IL-1Ra-ABD against IL-1β in A375 and HEK293 cell lines.

Findings/results: The stable complex of IL-1Ra-ABD with IL-1R established the absence of steric hindrance due to the addition of ABD to IL-1Ra. The expression induction of intein 1-IL-1Ra-ABD using 0.1 mM IPTG at 15 °C, and its cleavage represented bands approximately in 50 and 23 kDa. Furthermore, about 78% of IL-1Ra-ABD was attached to the HSA after 2 h of incubation, and the MTT assay showed no significant differences between the effects of IL-1Ra-ABD and native IL-1Ra in cell survival.

Conclusions and implications: The production of soluble IL-1Ra-ABD with no significant differences in IL-1Ra antagonizing effects was successfully performed. IL-1Ra-ABD showed suitable interaction with HSA and was released over time. However, the half-life of IL-1Ra-ABD in vivo must be determined in the subsequent investigations.

背景和目的:由于 Anakinra 的半衰期较短,必须每天注射,这导致患者的依从性较低。因此,本研究旨在制备一种白细胞介素-1受体拮抗剂(IL-1Ra)与白蛋白结合域(ABD)的新型融合蛋白,并评估其与白蛋白的结合能力及其生物效应:实验方法:用 MODELLER 软件预测了 IL-1Ra-ABD 的三维结构,并用 HADDOCK 服务器评估了它与 IL-1R 的相互作用。IL-1Ra-ABD在大肠杆菌中与pTWIN1的内含素1融合,以可溶性形式表达,然后纯化。通过原生聚合酶链式反应(native-PAGE)测定了IL-1Ra-ABD与人血清白蛋白(HSA)的亲和力,并评估了其释放时间百分比。此外,还利用 MTT 试验测定了重组 IL-1Ra-ABD 在 A375 和 HEK293 细胞系中对 IL-1β 的拮抗特性:IL-1Ra-ABD与IL-1R的稳定复合物确定了IL-1Ra与ABD之间不存在立体阻碍。在 15 °C 下使用 0.1 mM IPTG 诱导内切蛋白 1-IL-1Ra-ABD 的表达,其裂解代表了约 50 和 23 kDa 的条带。此外,培养 2 小时后,约 78% 的 IL-1Ra-ABD 附着在 HSA 上,MTT 试验显示 IL-1Ra-ABD 和原生 IL-1Ra 对细胞存活的影响无显著差异:成功制备了可溶性 IL-1Ra-ABD,其拮抗 IL-1Ra 的效果无显著差异。IL-1Ra-ABD 与 HSA 发生了适当的相互作用,并随着时间的推移而释放。然而,IL-1Ra-ABD 在体内的半衰期必须在后续研究中确定。
{"title":"Recombinant production of interleukin-1 receptor antagonist in fusion to albumin binding domain with potential affinity to human serum albumin.","authors":"Fatemeh Shafiee, Ali Yazdani","doi":"10.4103/RPS.RPS_41_23","DOIUrl":"10.4103/RPS.RPS_41_23","url":null,"abstract":"<p><strong>Background and purpose: </strong>Anakinra must be injected daily due to its short half-life and this leads to lower patient compliance. Therefore, the aim of this study was to produce an interleukin-1 receptor antagonist (IL-1Ra) with albumin binding domain (ABD) as a novel fusion protein and evaluate its binding ability to albumin and its biological effects.</p><p><strong>Experimental approach: </strong>The three-dimensional structure of IL-1Ra-ABD was predicted by MODELLER software and its interaction with IL-1R was evaluated by the HADDOCK server. The expression of IL-1Ra-ABD was performed in <i>E. coli</i> in fusion with intein 1 of pTWIN1 in soluble form and then purified. The affinity of IL-1Ra-ABD to human serum albumin (HSA) was determined on native-PAGE, and its release percent toward time was evaluated. Moreover, an MTT assay was used to determine the antagonizing properties of recombinant IL-1Ra-ABD against IL-1β in A375 and HEK293 cell lines.</p><p><strong>Findings/results: </strong>The stable complex of IL-1Ra-ABD with IL-1R established the absence of steric hindrance due to the addition of ABD to IL-1Ra. The expression induction of intein 1-IL-1Ra-ABD using 0.1 mM IPTG at 15 °C, and its cleavage represented bands approximately in 50 and 23 kDa. Furthermore, about 78% of IL-1Ra-ABD was attached to the HSA after 2 h of incubation, and the MTT assay showed no significant differences between the effects of IL-1Ra-ABD and native IL-1Ra in cell survival.</p><p><strong>Conclusions and implications: </strong>The production of soluble IL-1Ra-ABD with no significant differences in IL-1Ra antagonizing effects was successfully performed. IL-1Ra-ABD showed suitable interaction with HSA and was released over time. However, the half-life of IL-1Ra-ABD <i>in vivo</i> must be determined in the subsequent investigations.</p>","PeriodicalId":21075,"journal":{"name":"Research in Pharmaceutical Sciences","volume":"19 3","pages":"356-365"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11257196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Persianolide-A, an eudesmanolide-type sesquiterpene lactone from Artemisia kopetdaghensis, induces apoptosis by regulating ERK signaling pathways. Persianolide-A是一种来自茵陈蒿的桉叶内酯类倍半萜内酯,可通过调节ERK信号通路诱导细胞凋亡。
IF 2.1 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-07-01 eCollection Date: 2024-06-01 DOI: 10.4103/RPS.RPS_175_23
Seyyed Moein Ebrahimi, Jahanbakhsh Asadi, Maryam Fattahian, Seyyed Mehdi Jafari, Mustafa Ghanadian

Background and purpose: Herbal components, particularly sesquiterpenes, are progressively recognized as a crucial resource for developing effective therapeutic agents for breast cancer. In this study, the effect of a sesquiterpene lactone known as 8-O-dihydroxy-11a,13-dihydroeudesma-4(15)-en-12,6a-olide (persianolide- A) was examined in breast cancer cell lines.

Experimental approach: MDA-MB-231 and MCF-7 cancer cells were grown in DMEM solution with 10% FBS. Then, an MTT assay was performed to evaluate cell viability. Apoptosis was detected by annexin-PI staining. A caspase 3/7 activity assay kit was used to assess the activity of caspase-3 and caspase-7. Protein expression of Bcl-2, Bax, and p-ERK1/2 was determined by western blotting.

Findings/results: This study showed that the IC50 values of the persianolide-A for MCF-7 and MDA-MB- 468 cells are 34.76 and 54.48 μM, respectively. In addition, persianolide-A showed a significant increase in apoptosis in both MDAMB-231 and MCF-7 breast cancer cell lines. Persianolide-A significantly increased the expression of the pro-apoptotic protein Bax and decreased the expression of the anti-apoptotic protein Bcl-2. Also, presinolide-A treatment led to a substantial increase in caspase activity with a ratio of 3/7 in both MCF- 7 and MDA-MB-231 cancer cells. In addition, the study showed that persianolide-A decreased the expression of p-ERK1/2 protein.

Conclusion and implications: The results of this study suggest that persianolide-A, sourced from Artemisia kopetdaghensis, induces cell apoptosis in breast cancer cell types. The molecular mechanisms could be implicated in the modulation of the ERK1/2 signaling pathway.

背景和目的:草药成分,尤其是倍半萜类化合物,逐渐被认为是开发乳腺癌有效治疗药物的重要资源。在本研究中,研究了一种名为 8-O-二羟基-11a,13-二氢桉叶-4(15)-烯-12,6a-内酯(persianolide- A)的倍半萜内酯对乳腺癌细胞株的影响:实验方法:MDA-MB-231 和 MCF-7 癌细胞在含有 10% FBS 的 DMEM 溶液中生长。实验方法:MDA-MB-231 和 MCF-7 癌细胞在含有 10% FBS 的 DMEM 溶液中生长,然后进行 MTT 检测以评估细胞活力。通过 annexin-PI 染色检测细胞凋亡。caspase 3/7 活性检测试剂盒用于评估 caspase-3 和 caspase-7 的活性。Bcl-2、Bax和p-ERK1/2的蛋白表达通过Western印迹法测定:研究结果表明,persianolide-A 对 MCF-7 和 MDA-MB- 468 细胞的 IC50 值分别为 34.76 和 54.48 μM。此外,persianolide-A 对 MDAMB-231 和 MCF-7 乳腺癌细胞株的细胞凋亡率都有显著提高。persianolide-A能明显增加促凋亡蛋白Bax的表达,降低抗凋亡蛋白Bcl-2的表达。此外,在 MCF- 7 和 MDA-MB-231 癌细胞中,presinolide-A 处理导致 caspase 活性大幅增加,比例达到 3/7。此外,研究还显示,persianolide-A 还能降低 p-ERK1/2 蛋白的表达:本研究的结果表明,提取自青蒿的 persianolide-A 能诱导乳腺癌细胞凋亡。其分子机制可能与调节 ERK1/2 信号通路有关。
{"title":"Persianolide-A, an eudesmanolide-type sesquiterpene lactone from <i>Artemisia kopetdaghensis</i>, induces apoptosis by regulating ERK signaling pathways.","authors":"Seyyed Moein Ebrahimi, Jahanbakhsh Asadi, Maryam Fattahian, Seyyed Mehdi Jafari, Mustafa Ghanadian","doi":"10.4103/RPS.RPS_175_23","DOIUrl":"10.4103/RPS.RPS_175_23","url":null,"abstract":"<p><strong>Background and purpose: </strong>Herbal components, particularly sesquiterpenes, are progressively recognized as a crucial resource for developing effective therapeutic agents for breast cancer. In this study, the effect of a sesquiterpene lactone known as 8-O-dihydroxy-11a,13-dihydroeudesma-4(15)-en-12,6a-olide (persianolide- A) was examined in breast cancer cell lines.</p><p><strong>Experimental approach: </strong>MDA-MB-231 and MCF-7 cancer cells were grown in DMEM solution with 10% FBS. Then, an MTT assay was performed to evaluate cell viability. Apoptosis was detected by annexin-PI staining. A caspase 3/7 activity assay kit was used to assess the activity of caspase-3 and caspase-7. Protein expression of Bcl-2, Bax, and p-ERK1/2 was determined by western blotting.</p><p><strong>Findings/results: </strong>This study showed that the IC<sub>50</sub> values of the persianolide-A for MCF-7 and MDA-MB- 468 cells are 34.76 and 54.48 μM, respectively. In addition, persianolide-A showed a significant increase in apoptosis in both MDAMB-231 and MCF-7 breast cancer cell lines. Persianolide-A significantly increased the expression of the pro-apoptotic protein Bax and decreased the expression of the anti-apoptotic protein Bcl-2. Also, presinolide-A treatment led to a substantial increase in caspase activity with a ratio of 3/7 in both MCF- 7 and MDA-MB-231 cancer cells. In addition, the study showed that persianolide-A decreased the expression of p-ERK1/2 protein.</p><p><strong>Conclusion and implications: </strong>The results of this study suggest that persianolide-A, sourced from <i>Artemisia kopetdaghensis,</i> induces cell apoptosis in breast cancer cell types. The molecular mechanisms could be implicated in the modulation of the ERK1/2 signaling pathway.</p>","PeriodicalId":21075,"journal":{"name":"Research in Pharmaceutical Sciences","volume":"19 3","pages":"328-337"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11257198/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Tamarindus indica L. fruit pulp and seed extracts on experimental ulcerative colitis in rats. 罗望子果肉和种子提取物对大鼠实验性溃疡性结肠炎的影响
IF 2.1 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-07-01 eCollection Date: 2024-06-01 DOI: 10.4103/RPS.RPS_131_23
Mohsen Minaiyan, Sepehr Abolhasani, Setareh Sima, Afsaneh Yegdaneh

Background and purpose: Tamarindus indica L. which has anti-inflammatory, radical scavenging, and ulcer healing effects can be useful for the alleviation of inflammatory bowel disease (IBD). Therefore, the effects of T. indica fruit pulp (TIPE) and seed extracts (TISE) were investigated on experimental colitis.

Experimental approach: TIPE and TISE (125, 250, and 500 mg/kg) were made by maceration (ethanol/water: 80/30) and administered to male Wistar rats with acetic acid-induced colitis. Prednisolone (4 mg/kg) and mesalazine (100 mg/kg) were used as reference drugs. The colon tissues were examined for macroscopic and pathologic parameters and myeloperoxidase (MPO) and malondialdehyde (MDA) values.

Findings/results: The total phenols were 45.7 ± 1.1 and 453.0 ± 3.3 mg/g in terms of gallic acid for TIPE and TISE, respectively. Both of the extracts significantly improved most of the investigated parameters including body weight loss, the weight of colons, indices of ulcers, and total colitis. MPO activity and MDA in the treatment groups (except for TIPE at 125 mg/Kg) significantly decreased compared to the control.

Conclusion and implications: Both TIPE and TISE were effective in the treatment of colitis however it seems that the effective ingredients were more concentrated in seeds rather than pulp extract so the highest dose of seed extract had a competitive effect with reference drugs. More studies are needed to introduce T. indica as a suitable complementary medicine or food for patients with IBD.

背景和目的:罗望子(Tamarindus indica L.)具有抗炎、清除自由基和愈合溃疡的作用,可用于缓解炎症性肠病(IBD)。因此,研究了 T. indica 果肉(TIPE)和种子提取物(TISE)对实验性结肠炎的影响:实验方法:用浸渍法(乙醇/水:80/30)制成 TIPE 和 TISE(125、250 和 500 毫克/千克),并给醋酸诱发结肠炎的雄性 Wistar 大鼠服用。泼尼松龙(4 毫克/千克)和美沙拉秦(100 毫克/千克)为参照药物。对结肠组织的宏观和病理参数以及髓过氧化物酶(MPO)和丙二醛(MDA)值进行了检查:以没食子酸计,TIPE 和 TISE 的总酚含量分别为 45.7 ± 1.1 和 453.0 ± 3.3 mg/g。两种提取物都能明显改善大多数调查参数,包括体重减轻、结肠重量、溃疡指数和总结肠炎。与对照组相比,治疗组(125 毫克/千克的 TIPE 除外)的 MPO 活性和 MDA 均明显降低:TIPE和TISE都能有效治疗结肠炎,但种子中的有效成分似乎比果肉提取物更集中,因此最高剂量的种子提取物与参考药物相比具有竞争效果。需要进行更多的研究,以便将 T. indica 作为 IBD 患者的合适辅助药物或食物。
{"title":"Effect of <i>Tamarindus indica</i> L. fruit pulp and seed extracts on experimental ulcerative colitis in rats.","authors":"Mohsen Minaiyan, Sepehr Abolhasani, Setareh Sima, Afsaneh Yegdaneh","doi":"10.4103/RPS.RPS_131_23","DOIUrl":"10.4103/RPS.RPS_131_23","url":null,"abstract":"<p><strong>Background and purpose: </strong><i>Tamarindus indica</i> L. which has anti-inflammatory, radical scavenging, and ulcer healing effects can be useful for the alleviation of inflammatory bowel disease (IBD). Therefore, the effects of <i>T. indica</i> fruit pulp (TIPE) and seed extracts (TISE) were investigated on experimental colitis.</p><p><strong>Experimental approach: </strong>TIPE and TISE (125, 250, and 500 mg/kg) were made by maceration (ethanol/water: 80/30) and administered to male Wistar rats with acetic acid-induced colitis. Prednisolone (4 mg/kg) and mesalazine (100 mg/kg) were used as reference drugs. The colon tissues were examined for macroscopic and pathologic parameters and myeloperoxidase (MPO) and malondialdehyde (MDA) values.</p><p><strong>Findings/results: </strong>The total phenols were 45.7 ± 1.1 and 453.0 ± 3.3 mg/g in terms of gallic acid for TIPE and TISE, respectively. Both of the extracts significantly improved most of the investigated parameters including body weight loss, the weight of colons, indices of ulcers, and total colitis. MPO activity and MDA in the treatment groups (except for TIPE at 125 mg/Kg) significantly decreased compared to the control.</p><p><strong>Conclusion and implications: </strong>Both TIPE and TISE were effective in the treatment of colitis however it seems that the effective ingredients were more concentrated in seeds rather than pulp extract so the highest dose of seed extract had a competitive effect with reference drugs. More studies are needed to introduce <i>T. indica</i> as a suitable complementary medicine or food for patients with IBD.</p>","PeriodicalId":21075,"journal":{"name":"Research in Pharmaceutical Sciences","volume":"19 3","pages":"276-286"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11257200/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacological evaluation of anti-inflammatory, antipyretic, analgesic, and antioxidant activities of Castanopsis costata leaf fractions (water, ethyl acetate, and n-hexane fractions): the potential medicinal plants from North Sumatra, Indonesia. 对印度尼西亚北苏门答腊潜在药用植物 Castanopsis costata 叶片馏分(水、乙酸乙酯和正己烷馏分)的抗炎、解热、镇痛和抗氧化活性进行药理评估。
IF 2.1 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-07-01 eCollection Date: 2024-06-01 DOI: 10.4103/RPS.RPS_201_23
Maulana Yusuf Alkandahri, Asman Sadino, Barolym Tri Pamungkas, Zulpakor Oktoba, Maya Arfania, Nia Yuniarsih, Eko Sri Wahyuningsih, Dea Eka Putri

Background and purpose: Inflammation, fever, and pain can be associated with several diseases, and the synthetic drugs used in the treatment of these conditions often have severe side effects. As a result, there is a need for effective, economical, and safe alternative drugs, such as those derived from medicinal plants. Therefore, this study aimed to evaluate the anti-inflammatory, antipyretic, analgesic, and antioxidant activities of Castanopsis costata leaf fractions (CcLF), as well as its acute toxicity.

Experimental approach: For anti-inflammatory, antipyretic, and analgesic tests, rats were given CcLF (WFCC, EAFcC, and n-HFCC) at 50 and 100 mg/kg, diclofenac sodium (10 mg/kg), paracetamol (150 mg/kg), aspirin (100 mg/kg), and tramadol (20 mg/kg). For the antioxidant activity test, various concentrations of CcLF were used ranging from 25 to 200 μg/mL. This study also looked into whether there could be any acute toxicity and histopathology of the liver, stomach, and kidneys in experimental animals.

Findings/results: The administration of CcLF significantly inhibited the increase in foot edema volume, and CcLF (EAFCC at 100 mg/kg) considerably decreased rectal temperature and was proportional to the standard drug paracetamol, and significantly inhibited pain sensation in various models. Additionally, CcLF showed strong antioxidant activity, and its administration at a dose limit of 5000 mg/kg/day did not show any toxic effects or death in test animals.

Conclusions and implications: The results of the current confirmed that CcLF has demonstrated anti-inflammatory, antipyretic, analgesic, and antioxidant properties in experimental models, and is practically non-toxic.

背景和目的:炎症、发烧和疼痛可能与多种疾病相关,而用于治疗这些疾病的合成药物往往具有严重的副作用。因此,需要有效、经济、安全的替代药物,例如从药用植物中提取的药物。因此,本研究旨在评估拟南芥叶馏分(CcLF)的抗炎、解热、镇痛和抗氧化活性及其急性毒性:在抗炎、解热和镇痛试验中,给大鼠服用 CcLF(WFCC、EAFcC 和 n-HFCC)(50 和 100 毫克/千克)、双氯芬酸钠(10 毫克/千克)、扑热息痛(150 毫克/千克)、阿司匹林(100 毫克/千克)和曲马多(20 毫克/千克)。在抗氧化活性测试中,使用了25至200微克/毫升不同浓度的CcLF。这项研究还考察了实验动物的肝、胃和肾是否存在急性毒性和组织病理学:服用CcLF可明显抑制足部水肿体积的增加,CcLF(EAFCC 100 mg/kg)可明显降低直肠温度,与标准药物扑热息痛成正比,并可明显抑制各种模型的痛觉。此外,CcLF还具有很强的抗氧化活性,在5000毫克/千克/天的剂量限制下,试验动物没有出现任何毒性反应或死亡:目前的研究结果证实,CcLF 在实验模型中具有抗炎、解热、镇痛和抗氧化特性,而且实际上是无毒的。
{"title":"Pharmacological evaluation of anti-inflammatory, antipyretic, analgesic, and antioxidant activities of <i>Castanopsis costata</i> leaf fractions (water, ethyl acetate, and <i>n</i>-hexane fractions): the potential medicinal plants from North Sumatra, Indonesia.","authors":"Maulana Yusuf Alkandahri, Asman Sadino, Barolym Tri Pamungkas, Zulpakor Oktoba, Maya Arfania, Nia Yuniarsih, Eko Sri Wahyuningsih, Dea Eka Putri","doi":"10.4103/RPS.RPS_201_23","DOIUrl":"10.4103/RPS.RPS_201_23","url":null,"abstract":"<p><strong>Background and purpose: </strong>Inflammation, fever, and pain can be associated with several diseases, and the synthetic drugs used in the treatment of these conditions often have severe side effects. As a result, there is a need for effective, economical, and safe alternative drugs, such as those derived from medicinal plants. Therefore, this study aimed to evaluate the anti-inflammatory, antipyretic, analgesic, and antioxidant activities of <i>Castanopsis costata</i> leaf fractions (CcLF), as well as its acute toxicity.</p><p><strong>Experimental approach: </strong>For anti-inflammatory, antipyretic, and analgesic tests, rats were given CcLF (WFCC, EAFcC, and <i>n</i>-HFCC) at 50 and 100 mg/kg, diclofenac sodium (10 mg/kg), paracetamol (150 mg/kg), aspirin (100 mg/kg), and tramadol (20 mg/kg). For the antioxidant activity test, various concentrations of CcLF were used ranging from 25 to 200 μg/mL. This study also looked into whether there could be any acute toxicity and histopathology of the liver, stomach, and kidneys in experimental animals.</p><p><strong>Findings/results: </strong>The administration of CcLF significantly inhibited the increase in foot edema volume, and CcLF (EAFCC at 100 mg/kg) considerably decreased rectal temperature and was proportional to the standard drug paracetamol, and significantly inhibited pain sensation in various models. Additionally, CcLF showed strong antioxidant activity, and its administration at a dose limit of 5000 mg/kg/day did not show any toxic effects or death in test animals.</p><p><strong>Conclusions and implications: </strong>The results of the current confirmed that CcLF has demonstrated anti-inflammatory, antipyretic, analgesic, and antioxidant properties in experimental models, and is practically non-toxic.</p>","PeriodicalId":21075,"journal":{"name":"Research in Pharmaceutical Sciences","volume":"19 3","pages":"251-266"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11257201/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of Dracocephalum subcapitatum hydroalcoholic extract on dexamethasone-induced hyperlipidemic rats. 亚头状花序水醇提取物对地塞米松诱导的高脂血症大鼠的影响
IF 2.1 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-07-01 eCollection Date: 2024-06-01 DOI: 10.4103/RPS.RPS_148_23
Leila Safaeian, Zeinab Yazdiniapour, Sara Hajibagher, Zohreh Bakhtiari, Paridokht Karimian

Background and purpose: Recent data show the antihyperlipidemic activities of some plants belonging to the genus Dracocephalum. In this study, the effects of hydroalcoholic extract of D. subcapitatum (O. Kuntze) Lipsky aerial parts were evaluated in a model of hyperlipidemia induced by dexamethasone.

Experimental approach: The extract was prepared by maceration method and its total phenolic content was determined. Seven groups of 6 Wistar rats were used as follows: group 1 (normal control) received vehicle; group 2 (extract control) treated only with 200 mg/kg D. subcapitatum; group 3 (hyperlipidemia control) received dexamethasone (10 mg/kg/day, subcutaneously); group 4 (reference) received dexamethasone and atorvastatin (40 mg/kg, orally), and groups 5-7 (test groups) received dexamethasone and simultaneously treated orally with 50, 100, or 200 mg/kg D. subcapitatum. All treatments were done for 1 week. Serum lipid profile, fasting blood glucose, malondialdehyde concentration, and liver histopathology were examined.

Findings/results: Total phenolic content was 77.34 ± 4.9 mg/g as gallic acid equivalent. Treatment with D. subcapitatum (200 mg/kg) meaningfully declined triglycerides, total cholesterol, low-density lipoprotein, very low-density lipoprotein, blood glucose, alanine aminotransferase, aspartate aminotransferase, and malondialdehyde levels, and alleviated hepatic steatosis in dexamethasone-induced dyslipidemic rats.

Conclusion and implications: Findings of the current study suggest that D. subcapitatum may be effective in the management of hyperlipidemia. Further studies are necessary to determine the clinical efficacy of this treatment and to understand the underlying mechanisms responsible for its ability to lower lipid levels.

背景和目的:最新数据显示,龙脑属的一些植物具有抗高脂血症活性。本研究评估了 D. subcapitatum (O. Kuntze) Lipsky 气生部分水醇提取物在地塞米松诱导的高脂血症模型中的作用:实验方法:浸渍法制备提取物并测定其总酚含量。实验方法:采用浸泡法制备提取物,并测定其总酚含量。7 组 6 只 Wistar 大鼠的实验结果如下:第 1 组(正常对照组)接受药物治疗;第 2 组(提取物对照组)仅接受 200 mg/kg D.亚卡比妥;第 3 组(高脂血症对照组)服用地塞米松(10 毫克/千克/天,皮下注射);第 4 组(参照组)服用地塞米松和阿托伐他汀(40 毫克/千克,口服);第 5-7 组(试验组)服用地塞米松,同时口服 50、100 或 200 毫克/千克的亚卡比妥。所有治疗均持续 1 周。对血脂概况、空腹血糖、丙二醛浓度和肝组织病理学进行了检查:总酚含量为 77.34 ± 4.9 mg/g(没食子酸当量)。亚头孢烷基二氢萘 (D. subcapitatum) 治疗(200 毫克/千克)可有效降低甘油三酯、总胆固醇、低密度脂蛋白、极低密度脂蛋白、血糖、丙氨酸氨基转移酶、天门冬氨酸氨基转移酶和丙二醛水平,并缓解地塞米松诱导的血脂异常大鼠的肝脂肪变性:目前的研究结果表明,D. subcapitatum 可有效治疗高脂血症。有必要开展进一步研究,以确定这种疗法的临床疗效,并了解其降低血脂水平的潜在机制。
{"title":"The effect of <i>Dracocephalum subcapitatum</i> hydroalcoholic extract on dexamethasone-induced hyperlipidemic rats.","authors":"Leila Safaeian, Zeinab Yazdiniapour, Sara Hajibagher, Zohreh Bakhtiari, Paridokht Karimian","doi":"10.4103/RPS.RPS_148_23","DOIUrl":"10.4103/RPS.RPS_148_23","url":null,"abstract":"<p><strong>Background and purpose: </strong>Recent data show the antihyperlipidemic activities of some plants belonging to the genus <i>Dracocephalum</i>. In this study, the effects of hydroalcoholic extract of <i>D. subcapitatum</i> (O. Kuntze) Lipsky aerial parts were evaluated in a model of hyperlipidemia induced by dexamethasone.</p><p><strong>Experimental approach: </strong>The extract was prepared by maceration method and its total phenolic content was determined. Seven groups of 6 Wistar rats were used as follows: group 1 (normal control) received vehicle; group 2 (extract control) treated only with 200 mg/kg <i>D. subcapitatum;</i> group 3 (hyperlipidemia control) received dexamethasone (10 mg/kg/day, subcutaneously); group 4 (reference) received dexamethasone and atorvastatin (40 mg/kg, orally), and groups 5-7 (test groups) received dexamethasone and simultaneously treated orally with 50, 100, or 200 mg/kg <i>D. subcapitatum</i>. All treatments were done for 1 week. Serum lipid profile, fasting blood glucose, malondialdehyde concentration, and liver histopathology were examined.</p><p><strong>Findings/results: </strong>Total phenolic content was 77.34 ± 4.9 mg/g as gallic acid equivalent. Treatment with <i>D. subcapitatum</i> (200 mg/kg) meaningfully declined triglycerides, total cholesterol, low-density lipoprotein, very low-density lipoprotein, blood glucose, alanine aminotransferase, aspartate aminotransferase, and malondialdehyde levels, and alleviated hepatic steatosis in dexamethasone-induced dyslipidemic rats.</p><p><strong>Conclusion and implications: </strong>Findings of the current study suggest that <i>D. subcapitatum</i> may be effective in the management of hyperlipidemia. Further studies are necessary to determine the clinical efficacy of this treatment and to understand the underlying mechanisms responsible for its ability to lower lipid levels.</p>","PeriodicalId":21075,"journal":{"name":"Research in Pharmaceutical Sciences","volume":"19 3","pages":"319-327"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11257195/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spiroconjugated 1,2,3-triazolo[5,1-b]1,3,4-thiadiazine stimulates functional activity of fibroblasts under skin injury regeneration. 螺共轭 1,2,3-三唑并[5,1-b]1,3,4-噻二嗪可刺激皮肤损伤再生过程中成纤维细胞的功能活性。
IF 2.1 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-07-01 eCollection Date: 2024-06-01 DOI: 10.4103/RPS.RPS_74_23
Irina M Petrova, Sofya Iu Chebanova, Sergey L Khatsko, Tatyana A Kalinina, Dmitry V Zaitsev, Tatyana V Glukhareva

Background and purpose: One of the most important mechanisms of tissue regeneration is the high functional activity of cells, including proliferation. Currently, there are practically no effective skin cell activators on the pharmaceutical market. The purpose of this work was to demonstrate the stimulating effect of spiroconjugated 1,2,3-triazolo[5,1-b]1,3,4-thiadiazine (STT) on the functional activity of fibroblasts.

Experimental approach: STT containing ointment for dermal application was made. To assess in vivo effect of the STT a linear wound model in rats was tested. A combination of histological techniques and mechanical testing was employed to estimate the stimulating effect of STT on the functional activity of fibroblasts.

Findings/results: The STT significantly increased the number of fibroblasts as well as the density and order of produced collagen fibers in the dermis during the wound healing process. As a result, a tissue was formed at the site of damage with the structure corresponding to normal skin. In addition, skin functions were restored, in particular mechanically.

Conclusion and implications: The results suggested the stimulating effect of the STT on fibroblast activity and demonstrated its potential for skin regeneration.

背景和目的:组织再生最重要的机制之一是细胞的高功能活性,包括增殖。目前,医药市场上几乎没有有效的皮肤细胞激活剂。这项工作的目的是证明螺共轭 1,2,3-三唑并[5,1-b]1,3,4-噻二嗪(STT)对成纤维细胞功能活性的刺激作用:实验方法:制作含有 STT 的软膏,用于皮肤涂抹。为了评估 STT 的体内效应,对大鼠的线性伤口模型进行了测试。采用组织学技术和机械测试相结合的方法来评估 STT 对成纤维细胞功能活性的刺激作用:在伤口愈合过程中,STT 能明显增加成纤维细胞的数量以及真皮层中胶原纤维的密度和生成顺序。因此,在损伤部位形成了与正常皮肤结构相同的组织。此外,皮肤功能也得到了恢复,特别是在机械方面:结果表明,STT 对成纤维细胞的活性有刺激作用,并证明了其在皮肤再生方面的潜力。
{"title":"Spiroconjugated 1,2,3-triazolo[5,1-<i>b</i>]1,3,4-thiadiazine stimulates functional activity of fibroblasts under skin injury regeneration.","authors":"Irina M Petrova, Sofya Iu Chebanova, Sergey L Khatsko, Tatyana A Kalinina, Dmitry V Zaitsev, Tatyana V Glukhareva","doi":"10.4103/RPS.RPS_74_23","DOIUrl":"10.4103/RPS.RPS_74_23","url":null,"abstract":"<p><strong>Background and purpose: </strong>One of the most important mechanisms of tissue regeneration is the high functional activity of cells, including proliferation. Currently, there are practically no effective skin cell activators on the pharmaceutical market. The purpose of this work was to demonstrate the stimulating effect of spiroconjugated 1,2,3-triazolo[5,1-<i>b</i>]1,3,4-thiadiazine (STT) on the functional activity of fibroblasts.</p><p><strong>Experimental approach: </strong>STT containing ointment for dermal application was made. To assess <i>in vivo</i> effect of the STT a linear wound model in rats was tested. A combination of histological techniques and mechanical testing was employed to estimate the stimulating effect of STT on the functional activity of fibroblasts.</p><p><strong>Findings/results: </strong>The STT significantly increased the number of fibroblasts as well as the density and order of produced collagen fibers in the dermis during the wound healing process. As a result, a tissue was formed at the site of damage with the structure corresponding to normal skin. In addition, skin functions were restored, in particular mechanically.</p><p><strong>Conclusion and implications: </strong>The results suggested the stimulating effect of the STT on fibroblast activity and demonstrated its potential for skin regeneration.</p>","PeriodicalId":21075,"journal":{"name":"Research in Pharmaceutical Sciences","volume":"19 3","pages":"267-275"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11257193/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The enhancement of M13 phage titration by optimizing the origin of replication. 通过优化复制源增强 M13 噬菌体的滴度。
IF 2.1 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-07-01 eCollection Date: 2024-06-01 DOI: 10.4103/RPS.RPS_14_24
Mohammad Hossein Darvishali, Mahmood Fadaie, Hossein Khanahmad

Background and purpose: M13KO7, a modified M13 phage variant, carries the p15A replication origin and Tn903 kanamycin resistance gene. This study aimed to optimize M13KO7's replication by substituting the p15A origin with the higher-copy pMB1 origin (500-700 copy numbers).

Experimental approach: A 6431-nucleotide fragment from the M13KO7 plasmid lacking the p15A replication origin and kanamycin resistance gene was amplified using a long polymerase chain reaction (PCR). The modified M13AMB1 plasmid was created by adding adenine to the 3' ends of this fragment and ligating it to the pMB1-containing fragment using T/A cloning. Afterward, to prepare the phage, pM13AMB1 was transformed into E. coli TG1 bacteria, and then, using the PEG-NaCl precipitation, the modified phage was propagated. The modified phage titer was determined utilizing the serial dilution and the qPCR methods, compared with the M13KO7 phage.

Findings/results: The results showed that in the serial dilution method, the titers of modified phage and M13KO7 phage were 4.8 × 1014 and 7 × 1012 pfu/mL, respectively. Besides, the phage titer calculated by the qPCR method for the modified phage was equal to 1.3 × 109 pfu/mL, whereas it was 4.08 × 108 pfu/mL for the M13KO7 phage.

Conclusion and implications: This study provides evidence that replication origin replacement led to a significant increase in phage titers. It highlights the importance of replication optimization for molecular biology applications.

背景与目的:M13KO7 是一种改良的 M13 噬菌体变体,携带 p15A 复制源和 Tn903 卡那霉素抗性基因。本研究旨在用高拷贝数的 pMB1 源(500-700 拷贝数)取代 p15A 源,从而优化 M13KO7 的复制:实验方法:使用长聚合酶链式反应(PCR)扩增缺少 p15A 复制源和卡那霉素抗性基因的 M13KO7 质粒的 6431 核苷酸片段。通过在该片段的 3' 端添加腺嘌呤,并使用 T/A 克隆将其连接到含有 pMB1 的片段上,从而创建了经修饰的 M13AMB1 质粒。之后,为了制备噬菌体,将 pM13AMB1 转化到大肠杆菌 TG1 中,然后用 PEG-NaCl 沉淀法繁殖改良噬菌体。利用序列稀释法和 qPCR 法测定改造噬菌体的滴度,并与 M13KO7 噬菌体进行比较:结果表明,在连续稀释法中,改良噬菌体和 M13KO7 噬菌体的滴度分别为 4.8 × 1014 和 7 × 1012 pfu/mL。此外,用 qPCR 方法计算出的改良噬菌体的噬菌体滴度等于 1.3 × 109 pfu/mL,而 M13KO7 噬菌体的滴度为 4.08 × 108 pfu/mL:本研究提供了复制源替换导致噬菌体滴度显著增加的证据。它突出了复制优化在分子生物学应用中的重要性。
{"title":"The enhancement of M13 phage titration by optimizing the origin of replication.","authors":"Mohammad Hossein Darvishali, Mahmood Fadaie, Hossein Khanahmad","doi":"10.4103/RPS.RPS_14_24","DOIUrl":"10.4103/RPS.RPS_14_24","url":null,"abstract":"<p><strong>Background and purpose: </strong>M13KO7, a modified M13 phage variant, carries the p15A replication origin and Tn903 kanamycin resistance gene. This study aimed to optimize M13KO7's replication by substituting the p15A origin with the higher-copy pMB1 origin (500-700 copy numbers).</p><p><strong>Experimental approach: </strong>A 6431-nucleotide fragment from the M13KO7 plasmid lacking the p15A replication origin and kanamycin resistance gene was amplified using a long polymerase chain reaction (PCR). The modified M13AMB1 plasmid was created by adding adenine to the 3' ends of this fragment and ligating it to the pMB1-containing fragment using T/A cloning. Afterward, to prepare the phage, pM13AMB1 was transformed into <i>E. coli</i> TG1 bacteria, and then, using the PEG-NaCl precipitation, the modified phage was propagated. The modified phage titer was determined utilizing the serial dilution and the qPCR methods, compared with the M13KO7 phage.</p><p><strong>Findings/results: </strong>The results showed that in the serial dilution method, the titers of modified phage and M13KO7 phage were 4.8 × 10<sup>14</sup> and 7 × 10<sup>12</sup> pfu/mL, respectively. Besides, the phage titer calculated by the qPCR method for the modified phage was equal to 1.3 × 10<sup>9</sup> pfu/mL, whereas it was 4.08 × 10<sup>8</sup> pfu/mL for the M13KO7 phage.</p><p><strong>Conclusion and implications: </strong>This study provides evidence that replication origin replacement led to a significant increase in phage titers. It highlights the importance of replication optimization for molecular biology applications.</p>","PeriodicalId":21075,"journal":{"name":"Research in Pharmaceutical Sciences","volume":"19 3","pages":"338-346"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11257199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isolation of two steroidal saponins with antileishmanial activity from Allium giganteum L. 从薤白中分离出两种具有抗利什曼病活性的甾体皂苷
IF 2.1 Q3 CHEMISTRY, MEDICINAL Pub Date : 2024-07-01 eCollection Date: 2024-06-01 DOI: 10.4103/RPS.RPS_71_21
Farnaz Chaparian, Zeinab Delazar, Masoud Sadeghi Dinani

Background and purpose: Alliums are rich sources of steroidal saponins, flavonoids, and sulphoric compounds of which steroidal saponins have recently received more attention due to their important pharmacological activities. Allium giganteum (giant onion) which is named locally "Couria" in the Northeast of Iran, is grown widely in "Kouh-Sorkh" mountains in Khorasan province.

Experimental approach: Phytochemical investigation of chloroform-methanol and aqueous extract of the plant resulted in the isolation and identification of two steroidal saponins, using comprehensive spectroscopic methods including 1D and 2D NMR and MS.

Findings/results: The chemical structures of the isolated saponins were determined as (22S)-cholesta-1b,3b,16b,22b-tetraol 5-en, and 3-O-β-D-glucopyranosyl26-O-β-D-glucopyranosside and (25R)-26-O-β-D-glucopyranosyl-5α-furostan-1α,3β,22α,26-tetraol3-O-{β-D-galactopyranosyl-(1→2)-O-[β-D-xylopyranosyl- (1→3)]-O-β-D-glucopyranosyl-(1→4)-β-D-galactopyranoside}. Investigation of in vitro antileishmanial activity of the isolated compounds at 10, 50, and 100 μg/mL exhibited significant leishmanicidal against the promastigotes of Leishmania major.

Conclusion and implications: The results established a valuable basis for further studies about A. giganteum and the anti-parasitic activity of steroidal saponins.

背景和目的:葱属植物是甾体皂甙、类黄酮和含硫化合物的丰富来源,其中甾体皂甙因其重要的药理活性最近受到越来越多的关注。大葱(Allium giganteum)在伊朗东北部被称为 "Couria",广泛生长在呼罗珊省的 "Kouh-Sorkh "山区:实验方法:对该植物的氯仿-甲醇提取物和水提取物进行植物化学研究,采用一维、二维核磁共振和质谱等综合光谱方法,分离并鉴定出两种甾体皂苷:分离出的皂苷的化学结构被确定为 (22S)-cholesta-1b,3b,16b,22b-tetraol 5-en、3-O-β-D-吡喃葡萄糖基 26-O-β-D-吡喃葡萄糖苷和 (25R)-26-O-β-D-吡喃葡萄糖基-5α-呋喃甾-1α、3β,22α,26-四醇3-O-{β-D-吡喃半乳糖基-(1→2)-O-[β-D-吡喃木糖基-(1→3)]-O-β-D-吡喃葡萄糖基-(1→4)-β-D-吡喃半乳糖苷}。在 10、50 和 100 μg/mL 的浓度下,对分离化合物的体外抗利什曼活性进行了研究,结果表明这些化合物对大利什曼原虫有显著的杀利什曼作用:这些结果为进一步研究千头椿和甾体皂苷的抗寄生虫活性奠定了宝贵的基础。
{"title":"Isolation of two steroidal saponins with antileishmanial activity from <i>Allium giganteum</i> L.","authors":"Farnaz Chaparian, Zeinab Delazar, Masoud Sadeghi Dinani","doi":"10.4103/RPS.RPS_71_21","DOIUrl":"10.4103/RPS.RPS_71_21","url":null,"abstract":"<p><strong>Background and purpose: </strong>Alliums are rich sources of steroidal saponins, flavonoids, and sulphoric compounds of which steroidal saponins have recently received more attention due to their important pharmacological activities. <i>Allium giganteum</i> (giant onion) which is named locally \"Couria\" in the Northeast of Iran, is grown widely in \"Kouh-Sorkh\" mountains in Khorasan province.</p><p><strong>Experimental approach: </strong>Phytochemical investigation of chloroform-methanol and aqueous extract of the plant resulted in the isolation and identification of two steroidal saponins, using comprehensive spectroscopic methods including 1D and 2D NMR and MS.</p><p><strong>Findings/results: </strong>The chemical structures of the isolated saponins were determined as (22S)-cholesta-1b,3b,16b,22b-tetraol 5-en, and 3-O-β-D-glucopyranosyl26-O-β-D-glucopyranosside and (25R)-26-O-β-D-glucopyranosyl-5α-furostan-1α,3β,22α,26-tetraol3-O-{β-D-galactopyranosyl-(1→2)-O-[β-D-xylopyranosyl- (1→3)]-O-β-D-glucopyranosyl-(1→4)-β-D-galactopyranoside}. Investigation of <i>in vitro</i> antileishmanial activity of the isolated compounds at 10, 50, and 100 μg/mL exhibited significant leishmanicidal against the promastigotes of <i>Leishmania major</i>.</p><p><strong>Conclusion and implications: </strong>The results established a valuable basis for further studies about <i>A. giganteum</i> and the anti-parasitic activity of steroidal saponins.</p>","PeriodicalId":21075,"journal":{"name":"Research in Pharmaceutical Sciences","volume":"19 3","pages":"347-355"},"PeriodicalIF":2.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11257202/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Research in Pharmaceutical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1